Hydromorphone Hydrochloride Injection, Solution
Product Images NDC 0409-1283

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0409-1283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydromorphone 01)

Chemical structure of hydromorphone hydrochloride, depicting the molecular framework including phenol, ketone, hydroxyl groups, and the hydrochloride component.*

FDA Label Image

Logo (Hydromorphone 02)

FDA Label Image

Figure (Hydromorphone 03)

Instructional illustration showing a pre-use inspection checklist for Hydromorphone Hydrochloride injection solution in a syringe. It highlights checking for broken tamper seals, cracked glass, drug leakage, expired date, and particulate matter with warnings not to use if tamper seals are broken. It also advises confirming drug name, strength, dose, and route before administration, and includes notes about sterile field and needle handling.*

FDA Label Image

Figure (Hydromorphone 04)

Illustration showing two steps for preparing a syringe: first, twisting off the plunger rod cover to break and discard the tamper-evident seal, and second, twisting off and removing the luer tip cover from the syringe to break and discard its tamper-evident seal.*

FDA Label Image

Figure (Hydromorphone 05)

An instructional illustration showing three steps for using a syringe with Hydromorphone Hydrochloride injection. Step 3 depicts expelling air by advancing the plunger rod. Step 4 shows adjusting the dose by expelling extra volume from the syringe based on protocol. Step 5 demonstrates connecting the syringe to an access device or needle/blunt cannula at the administration site to deliver medication.*

FDA Label Image

Logo (Hydromorphone 06)

FDA Label Image

Principal Display Panel (1 mg/mL Syringe Label)

Label for Hydromorphone Hydrochloride injection, USP, 1 mg/mL solution by Hospira, Inc. The label includes dosage volume graduations for 0.5 mL and 1 mL and a lot number or batch code.*

FDA Label Image

Principal Display Panel (1 mg/mL Syringe Label)

Label for Hydromorphone Hydrochloride Injection, USP 1 mg/mL from Hospira, Inc. The label indicates use for intravenous, intramuscular, or subcutaneous injection in a 1 mL single-dose syringe. It includes a tamper-evident seal area and a barcode section.*

FDA Label Image

Principal Display Panel (1 mg/mL Syringe Cello Pack Label)

Hydromorphone Hydrochloride Injection, USP 1 mg/mL vial label for sterile aqueous injection. This label specifies use for intravenous, intramuscular, or subcutaneous administration, with packaging containing 10 NexJect 1 mL single-dose syringes with luer lock. The label includes storage instructions, formulation details, and manufacturer Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (2 mg/mL Syringe Label)

Hydromorphone Hydrochloride injection label displaying strength of 2 mg/mL. The label shows graduated markings for volume measurements of 0.5 mL and 1 mL. The label also includes the text Hydromorphone HCl Injection, USP and a code PAA140441. The label is from Hospira, Inc.*

FDA Label Image

Principal Display Panel (2 mg/mL Syringe Label)

Label for Hydromorphone Hydrochloride Injection USP, 2 mg/mL strength, in a 1 mL single-dose syringe. The injection is indicated for intravenous, intramuscular, or subcutaneous use and includes instructions to protect from light. The label displays the NDC 0409-1312-16 and is marked Rx only. It features tamper seals and a barcode area.*

FDA Label Image

Principal Display Panel (2 mg/mL Syringe Cello Pack Label)

Hydromorphone Hydrochloride Injection, USP 2 mg/mL label for intravenous, intramuscular, or subcutaneous use. The label indicates single-dose 1 mL syringes with luer lock, manufactured by Hospira, Inc., and includes storage instructions, protective measures from light, and inactive ingredients. NDC 0409-1312-36 is noted, along with barcodes and batch/expiration placeholders.*

FDA Label Image

Principal Display Panel (4 mg/mL Syringe Label)

Label of Hydromorphone Hydrochloride Injection, USP showing concentration 4 mg/mL. The label includes volume markings (0.5 mL and 1 mL) and the labeler identified as Hospira, Inc. The text highlights the product as Hydromorphone HCl injection solution.*

FDA Label Image

Principal Display Panel (4 mg/mL Syringe Label)

Label for Hydromorphone Hydrochloride Injection, USP 4 mg/mL single-dose syringe. Intended for intravenous, intramuscular, or subcutaneous use. The label includes dosage strength, usage routes, instructions to protect from light, Rx only status, and a tamper seal indicator. Labeler is Hospira, Inc.*

FDA Label Image

Principal Display Panel (4 mg/mL Syringe Cello Pack Label)

Hydromorphone Hydrochloride Injection, USP 4 mg/mL label by Hospira, Inc. The label specifies intravenous, intramuscular, or subcutaneous use. It contains 10 NexJect 1 mL single-dose syringes with luer lock (needle not included). Storage and usage instructions are provided, including protection from light, sterile aqueous injection, and usual dosing to be found in the package insert.*

FDA Label Image

Principal Display Panel (0.5 mg/0.5 mL Syringe Label)

Label for Hydromorphone Hydrochloride Injection, USP, with a strength of 0.5 mg per 0.5 mL. The label includes measurement markings indicating 0.5 mL volume and displays the labeler code PAA152907. The product is presented as an injection solution from Hospira, Inc.*

FDA Label Image

Principal Display Panel (0.5 mg/0.5 mL Syringe Label)

Label for Hydromorphone Hydrochloride Injection, USP, 0.5 mg/0.5 mL in a 0.5 mL single-dose syringe. The label includes administration routes (intravenous, intramuscular, or subcutaneous), a tamper seal with twist and pull instructions, a barcode, and storage instruction to protect from light. Labeled by Hospira, Inc.*

FDA Label Image

Principal Display Panel (0.5 mg/0.5 mL Syringe Cello Pack Label)

Label for Hydromorphone Hydrochloride Injection, USP 0.5 mg/0.5 mL by Hospira, Inc. The label indicates the solution is for intravenous, intramuscular, or subcutaneous use and contains 10 single-dose syringes with luer lock. It includes storage instructions, formulation details, and warnings about needle inclusion and solution discoloration. The NDC number 0409-4264-01 is shown along with barcodes and serialization information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.